Nolvadex Brochure Failure To Mention Cancer Risk Model Draws Ad Letter

A Nolvadex reprint carrier brochure distributed by Zeneca that does not mention the Gail Model breast cancer risk assessment tool misrepresents the indication for the tamoxifen product, FDA asserted.